NewsBenzingaNovoCure T3 BPA de $(0,09) dépasse l’estimation de $(0,24), les ventes de 193,399 M$ dépassent l’estimation de 182,233 M$ NovoCure T3 BPA de $(0,09) dépasse l’estimation de $(0,24), les ventes de 193,399 M$ dépassent l’estimation de 182,233 M$ Benzinga 2026.10.29 11:01 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Equal-Weight on Commercial Metals, Lowers Price Target to $63 Dow Falls Over 300 Points; Nvidia Posts Upbeat Earnings TD Cowen Maintains Hold on Calumet, Lowers Price Target to $37 If You Invested $100 In Cenovus Energy Stock 5 Years Ago, You Would Have This Much Today Wells Fargo Maintains Overweight on Cleveland-Cliffs, Raises Price Target to $18 TD Cowen Maintains Buy on BWX Technologies, Lowers Price Target to $180